Up to eleven percent of women of reproductive age could have endometriosis, an undiagnosed painful condition that makes the menstrual cycle harder and is linked to infertility. It’s caused by uterine tissue growth outside of the uterus and there is no cure. An injection therapy became...
You are here
Neurocrine Biosciences, Inc.
Company Information
Address
Neurocrine Biosciences, Inc.
12790 El Camino Real
San Diego, CA
92130
United States
Information
UEI: N/A
# of Employees: N/A
Ownership Information
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
NOVEL TYPE III INTERLEUKIN 1 RECEPTOR
Amount: $99,634.00N/A
SBIRPhase I1996Department of Health and Human Services -
CRF BINDING PROTEIN AND OBESITY
Amount: $100,000.00N/A
SBIRPhase I1996Department of Health and Human Services -
ACTH R ANTAGONISTS FOR THE TREATMENT OF HYPERCORTISOLISM
Amount: $91,000.00N/A
SBIRPhase I1996Department of Health and Human Services -
Anti Inflammatory/Effects of CRF Binding Protein
Amount: $100,000.00CRF, a 4l-amino acid peptide, plays a significant role in modulating inflammatory responses throughcoordinated actions in the nervous, endocrine and immune systems. CRF has indirect anti-inflammatorys ...
SBIRPhase I1995Department of Health and Human Services -
CRF Receptor Antagonists for Treatment of Cocaine Abuse
Amount: $95,025.00Stress plays a major role in the precipitation and maintenance of drug abuse. Recent data demonstrastressors to facilitate the acquisition of ethanol and cocaine self-administration. Corticotropin-rep ...
SBIRPhase I1995Department of Health and Human Services -
Novel CRF--Receptor
Amount: $100,000.00Corticotropin releasing factor (CRT), a 41 amino acid peptide, controls the anterior pituitary secradrenocorticotropin and other proopiomelanocortin products. CRT also coordinates the endocrine, behaa ...
SBIRPhase I1995Department of Health and Human Services -
CRF Binding Protein and Dementia
Amount: $77,250.00Corticotrophin releasing factor(CRF) has been implicated in cognitive function and neurologicalillness such as Alzheimer's disease (AD). Evidence includes large decreases in CRF and up-regulationof CR ...
SBIRPhase I1994Department of Health and Human Services -
Development of TCR Antagonists to MBP-Reactive T-Cells
Amount: $75,000.00Multiple sclerosis (MS) is a chronic immune mediated disease characterized by recurrent attacksof neurologic dysfunction due to damage to the central nervous system. An animal model of MS,experimental ...
SBIRPhase I1994Department of Health and Human Services -
Combinatorial Organic Synthesis of a CRF-R Antagonist
Amount: $77,250.00N/A
SBIRPhase I1994Department of Health and Human Services
